Progressive Care, Inc. (RXMD)
USD 2.11
(5.5%)
USD 2.11
(5.5%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.47 Million USD | 179.07% |
| 2022 | -1.86 Million USD | -298.44% |
| 2021 | -468.47 Thousand USD | -186.95% |
| 2020 | -163.25 Thousand USD | 51.47% |
| 2019 | -336.43 Thousand USD | 74.9% |
| 2018 | -1.16 Million USD | -534.08% |
| 2017 | 334.97 Thousand USD | -8.18% |
| 2016 | 351.37 Thousand USD | 161.21% |
| 2015 | -549.43 Thousand USD | -40.66% |
| 2014 | -390.6 Thousand USD | 9.28% |
| 2013 | -430.55 Thousand USD | 0.0% |
| 2011 | -3810.00 USD | -100.22% |
| 2010 | 1.85 Million USD | 1474.37% |
| 2009 | -126.34 Thousand USD | 8.02% |
| 2008 | -126.34 Thousand USD | -33.4% |
| 2007 | -102.96 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.27 Million USD | -1639.1% |
| 2024 Q1 | 555 Thousand USD | 103.81% |
| 2023 Q4 | 1.41 Million USD | 339.94% |
| 2023 Q1 | 129.09 Thousand USD | 175.46% |
| 2023 Q3 | -589.54 Thousand USD | -177.88% |
| 2023 Q2 | 756.98 Thousand USD | 486.4% |
| 2023 FY | - USD | 188.72% |
| 2022 Q1 | -85.97 Thousand USD | 82.43% |
| 2022 Q2 | -241.84 Thousand USD | -181.28% |
| 2022 Q3 | -1.36 Million USD | -464.58% |
| 2022 FY | - USD | -298.44% |
| 2022 Q4 | -171.08 Thousand USD | 87.47% |
| 2021 Q4 | -489.25 Thousand USD | -231.79% |
| 2021 Q2 | 94.82 Thousand USD | 121.3% |
| 2021 Q1 | -445.26 Thousand USD | -246.3% |
| 2021 Q3 | 371.22 Thousand USD | 291.49% |
| 2021 FY | - USD | -186.95% |
| 2020 Q2 | -288.9 Thousand USD | 52.36% |
| 2020 Q4 | 304.34 Thousand USD | -28.85% |
| 2020 FY | - USD | 51.47% |
| 2020 Q3 | 427.76 Thousand USD | 248.06% |
| 2020 Q1 | -606.46 Thousand USD | -243.83% |
| 2019 Q3 | -92 Thousand USD | 60.88% |
| 2019 FY | - USD | 74.9% |
| 2019 Q4 | 421.65 Thousand USD | 558.29% |
| 2019 Q1 | -407.71 Thousand USD | 19.94% |
| 2019 Q2 | -235.21 Thousand USD | 42.31% |
| 2018 Q4 | -509.24 Thousand USD | -11.13% |
| 2018 Q2 | -240.56 Thousand USD | -81.77% |
| 2018 FY | - USD | -534.08% |
| 2018 Q1 | -132.34 Thousand USD | -162.35% |
| 2018 Q3 | -458.23 Thousand USD | -90.48% |
| 2017 FY | - USD | -8.18% |
| 2017 Q4 | 212.24 Thousand USD | 1325.34% |
| 2017 Q3 | -17.32 Thousand USD | 82.13% |
| 2017 Q2 | -96.93 Thousand USD | -145.98% |
| 2017 Q1 | 210.8 Thousand USD | 17045.82% |
| 2016 Q1 | 148.08 Thousand USD | 124.44% |
| 2016 FY | - USD | 161.21% |
| 2016 Q3 | 57.22 Thousand USD | -56.72% |
| 2016 Q4 | -1244.00 USD | -102.17% |
| 2016 Q2 | 132.23 Thousand USD | -10.71% |
| 2015 Q1 | 57.46 Thousand USD | 379.83% |
| 2015 FY | - USD | -40.66% |
| 2015 Q2 | 103.64 Thousand USD | 80.36% |
| 2015 Q3 | -123.37 Thousand USD | -219.04% |
| 2015 Q4 | -605.98 Thousand USD | -391.17% |
| 2014 Q2 | -56.97 Thousand USD | 17.58% |
| 2014 Q3 | -118.61 Thousand USD | -108.19% |
| 2014 Q4 | -20.53 Thousand USD | 82.69% |
| 2014 Q1 | -69.13 Thousand USD | 0.0% |
| 2014 FY | - USD | 9.28% |
| 2013 FY | - USD | 0.0% |
| 2012 Q1 | -123.99 Thousand USD | -217.64% |
| 2012 Q2 | -35.39 Thousand USD | 71.46% |
| 2012 Q3 | -251.91 Thousand USD | -611.83% |
| 2011 Q4 | 105.4 Thousand USD | 204.1% |
| 2011 Q3 | -101.25 Thousand USD | -220.74% |
| 2011 Q2 | -31.56 Thousand USD | -187.23% |
| 2011 Q1 | 36.19 Thousand USD | -58.07% |
| 2011 FY | - USD | -100.22% |
| 2010 Q4 | 86.31 Thousand USD | 376.94% |
| 2010 Q2 | -16.41 Thousand USD | -57.08% |
| 2010 Q3 | -31.16 Thousand USD | -89.89% |
| 2010 FY | - USD | 1474.37% |
| 2010 Q1 | -10.44 Thousand USD | 59.76% |
| 2009 FY | - USD | 8.02% |
| 2009 Q3 | -19.53 Thousand USD | 15.14% |
| 2009 Q4 | -25.96 Thousand USD | -32.95% |
| 2009 Q2 | -23.01 Thousand USD | 23.62% |
| 2009 Q1 | -30.13 Thousand USD | -1.37% |
| 2008 Q4 | -29.72 Thousand USD | 31.62% |
| 2008 Q2 | -13.75 Thousand USD | 74.05% |
| 2008 FY | - USD | -33.4% |
| 2008 Q1 | -53 Thousand USD | -1.68% |
| 2008 Q3 | -43.46 Thousand USD | -216.04% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | -18.47 Thousand USD | 79.54% |
| 2007 Q2 | -90.27 Thousand USD | -2502.29% |
| 2007 Q1 | 3758.00 USD | 115.85% |
| 2007 Q4 | -52.12 Thousand USD | -182.16% |
| 2006 Q4 | -23.71 Thousand USD | 7.5% |
| 2006 Q3 | -25.63 Thousand USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BIMI International Medical Inc. | -15.33 Million USD | 109.623% |
| Leafly Holdings, Inc. | -5.73 Million USD | 125.741% |